Frailty in Randomised Controlled Trials of Glucose-Lowering Therapies for Type 2 Diabetes: An Individual Participant Data Meta-Analysis of Frailty Prevalence, Treatment Efficacy, and Adverse Events (2024)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.2139/ssrn.4877146
Publication URI: http://dx.doi.org/10.2139/ssrn.4877146
Type: Preprint